Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran

Introduction COVID-19 prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases are still under investigation. Materials and Methods This historical cohort study evaluated the survival time of hospitalized children (1 month–18 years old) with COVID-19 admitted from March 2020 to August 2021 to an educational hospital in Yazd, Iran. The follow-up of patients was performed at least one month after discharge. Results From 183 hospitalized cases, 24 children were deceased. The median age of patients was 5.41, and 54.2% were male. The survival rate after one-month follow-up was 0.88, and the most significant predictors associated with survival time were the male sex, positive history of hospitalization, lymphopenia, hypoxia, and length of stay more than two weeks using Bayesian Cox regression analysis. Conclusion Accurate estimation of the impact of predictors on poor outcomes may help healthcare providers use therapeutic protocols based on risk factors and healthcare requirements of each patient to improve their survival.

[1]  Ngo Ngọc Quang Minh,et al.  Risk factors for disease severity and mortality of children with Covid-19: A study at a Vietnamese Children's hospital , 2022, Journal of Infection and Chemotherapy.

[2]  A. Karimi,et al.  COVID-19 Mortality in Children: A Referral Center Experience from Iran (Mofid Children's Hospital, Tehran, Iran) , 2022, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[3]  K. Gersing,et al.  Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative , 2022, JAMA network open.

[4]  F. Farzadfar,et al.  Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran , 2021, BMC Pediatrics.

[5]  J. Meek,et al.  Risk Factors for Severe COVID-19 in Children. , 2021, Pediatrics.

[6]  G. Di Sante,et al.  Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection , 2021, The Lancet Child & Adolescent Health.

[7]  E. Colosimo,et al.  Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database , 2021, The Lancet Child & Adolescent Health.

[8]  Karen K. Wong,et al.  Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children , 2021, JAMA network open.

[9]  S. Dominguez,et al.  Risk Factors for Severe COVID-19 in Children. , 2021, The Pediatric infectious disease journal.

[10]  Sung‐Soo Park,et al.  Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study , 2021, Cancers.

[11]  D. Buonsenso,et al.  Preliminary evidence on long COVID in children , 2021, medRxiv.

[12]  M. Mansourian,et al.  COVID-19 infection in children: A systematic review and meta-analysis of clinical features and laboratory findings , 2021, Archives de Pédiatrie.

[13]  T. Kirby.  New variant of SARS-CoV-2 in UK causes surge of COVID-19 , 2021, The Lancet Respiratory Medicine.

[14]  M. Elghazali,et al.  Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia , 2020, medRxiv.

[15]  V. Ziaee,et al.  Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran , 2020, Epidemiology and Infection.

[16]  Sohan Seth,et al.  Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.

[17]  Xiaodong Sun,et al.  Attaching clinical significance to COVID-19-associated diarrhea , 2020, Life Sciences.

[18]  S. McLafferty,et al.  Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[19]  T. Flanigan,et al.  Predictors of COVID‐19 severity: A literature review , 2020, Reviews in medical virology.

[20]  Abby L. Berns,et al.  Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  M. Mehdizadeh,et al.  The Coronavirus Disease 2019 (COVID-19) in Children: A Study in an Iranian Children’s Referral Hospital , 2020, Infection and drug resistance.

[22]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[23]  Adam J. Schweickert,et al.  Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. , 2020, JAMA pediatrics.

[24]  Jianguo Wu,et al.  Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China , 2020, Frontiers in Cellular and Infection Microbiology.

[25]  Karsten M. Borgwardt,et al.  Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis , 2020, Travel Medicine and Infectious Disease.

[26]  Lynnette Brammer,et al.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[27]  Luan-Yin Chang,et al.  Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis , 2020, Journal of the Formosan Medical Association.

[28]  Jing Shi,et al.  Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.

[29]  Daniel C. Baumgart,et al.  Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management , 2020, Clinical Gastroenterology and Hepatology.

[30]  J. Ludvigsson.  Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.

[31]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[32]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[33]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[34]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.